RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Mar. 31, 2018

Table Text Block Supplement [Abstract]

Schedule of Related Party Transactions

Following is a summary of activity between the Company and Pharma and NDM for the years ended March 31, 2018, 2017 and 2016. These amounts are unsecured, interest free, and payable on demand.

	Year Ended March 31, 2018 ($)			Year Ended March 31, 2017 ($)			Year Ended March 31, 2016 ($)
Balance due from Pharma and NDM at beginning of period		(687,609	)		(494,145	)		192,484
Amounts advanced to Pharma		-			-			58,197
Amounts received from Pharma		(145,214	)		(2,480	)		(228,361	)
Reduction in prepayments to Pharma for clinical trials		-			-			(247,596	)
Amounts invoiced by Pharma to DDL, NM and TCL (1)		(842,739	)		(577,481	)		(331,714	)
Amounts invoiced by DDL to Pharma		-			15,305			16,307
Amounts repaid by DDL to Pharma		1,096,767			249,060			-
Amounts paid by DDL on behalf of Pharma		19,889			42,403			-
Sale of fixed and intangible assets to Pharma and NDM		-			-			17,775
Foreign exchange differences		(54,912	)		79,729			28,763
Net balance due to Pharma and NDM at end of the period		(613,818	)		(687,609	)		(494,145	)

(1) These amounts are included primarily in research and development expenses.